Hepatitis C Virus Infection, Autophagy, and Innate Immune Response

Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging

Volumn 3, Issue , 2014, Pages 163-172

  Shrivastava, Shubham ^a   Ray, Ratna B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy Innate Immune Response; Hepatitis C Virus (HCV); Interferon; Pathogen Recognition Receptor (PRR); Retinoic Acid Inducible Gene I (RIG I) Like Receptor (RLR); Toll like receptor (TLR)

Indexed keywords

EID: 84907682288     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405529-2.00011-1     Document Type: Chapter

References (44)

1. Abe T., Fukuhara T., Wen X., et al. CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan. J. Virol. 2012, 86:6159-6170.
2. Ait-Goughoulte M., Kanda T., Meyer K., et al. Hepatitis C virus genotype 1a growth and induction of autophagy. J. Virol. 2008, 82:2241-2249.
3. Arnaud N., Dabo S., Akazawa D., et al. Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog. 2011, 7:e1002289.
4. Bode J.G., Ludwig S., Ehrhardt C., et al. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 2003, 17:488-490.
5. Coenen M., Nischalke H.D., Krämer B., et al. Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2. Lab. Invest. 2011, 91:1375-1382.
6. Dreux M., Gastaminza P., Wieland S.F., et al. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl. Acad. Sci. USA 2009, 106:14046-14051.
7. Dreux M., Garaigorta U., Boyd B., et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012, 12:558-570.
8. Florentin J., Aouar B., Dental C., et al. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood 2012, 120:4544-4551.
9. Garaigorta U., Chisari F.V. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 2009, 6:513-522.
10. Grégoire I.P., Richetta C., Meyniel-Schicklin L., et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog. 2011, 7:e1002422.
11. Horsmans Y., Berg T., Desager J.P., et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 2005, 42:724-731.
12. Howell J., Sawhney R., Skinner N., et al. Toll-like receptor 3 and 7/8 function is impaired in hepatitis C rapid fibrosis progression post-liver transplantation. Am. J. Transplant. 2013, 13:943-953.
13. Kanda T., Steele R., Ray R., et al. Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J. Virol. 2007, 81:12375-12381.
14. Kaukinen P., Sillanpää M., Nousiainen L., et al. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions. J. Med. Virol. 2013, 85:71-82.
15. Ke P.Y., Chen S.S. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Invest. 2011, 121:37-56.
16. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
17. Li K., Lemon S.M. Innate immune responses in hepatitis C virus infection. Semin. Immunopathol. 2013, 35:53-72.
18. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
19. Marukian S., Andrus L., Sheahan T.P., et al. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology 2011, 54:1913-1923.
20. Metz P., Dazert E., Ruggieri A., et al. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 2012, 56:2082-2093.
21. Mizui T., Yamashina S., Tanida I., et al. Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J. Gastroenterol. 2010, 45:195-203.
22. Nitta S., Sakamoto N., Nakagawa M., et al. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology 2013, 57:46-58.
23. Oshiumi H., Ikeda M., Matsumoto M., et al. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction. PLoS One 2010, 5:e14258.
24. Rautou P.E., Cazals-Hatem D., Feldmann G., et al. Changes in autophagic response in patients with chronic hepatitis C virus infection. Am. J. Pathol. 2011, 178:2708-2715.
25. Raychoudhuri A., Shrivastava S., Steele R., et al. Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. J. Virol. 2010, 84:10991-10998.
26. Raychoudhuri A., Shrivastava S., Steele R., et al. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 2011, 85:12881-12889.
27. Ronit A., Salem M., Hartling H.J., et al. Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection. APMIS 2012, Oct(22). [Epub ahead of print]. 10.1111/apm.12013.
28. Saitoh T., Akira S. Regulation of innate immune responses by autophagy-related proteins. J. Cell Biol. 2010, 189:925-935.
29. Sarasin-Filipowicz M., Oakeley E.J., Duong F.H., et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. USA 2008, 105:7034-7039.
30. Schoggins J.W., Wilson S.J., Panis M., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
31. Shrivastava S., Raychoudhuri A., Steele R., et al. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 2011, 53:406-414.
32. Shrivastava S., Bhanja Chowdhury J., Steele R., et al. Hepatitis C virus upregulates Beclin-1 for induction of autophagy and activates mTOR signaling. J. Virol. 2012, 86:8705-8712.
33. Sir D., Chen W.L., Choi J., et al. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 2008, 48:1054-1061.
34. Soucy-Faulkner A., Mukawera E., Fink K., et al. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog. 2010, 6:e1000930.
35. Stark G.R., Darnell J.E The JAK-STAT pathway at twenty. Immunity 2012, 36:503-514.
36. Taguwa S., Kambara H., Fujita N., et al. Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus. J. Virol. 2011, 85:13185-13194.
37. Tanida I., Fukasawa M., Ueno T., et al. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy 2009, 5:937-945.
38. Thomas E., Gonzalez V.D., Li Q., et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 2012, 142:978-988.
39. Wang Y., Li J., Wang X., et al. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Innate Immun. 2013, Mar(25). [Epub ahead of print].
40. Welsch C., Jesudian A., Zeuzem S., et al. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. Gut 2012, 61(Suppl. 1):i36-i46.
41. Xin Z., Han W., Zhao Z., et al. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2. PLoS One 2011, 6:e25419.
42. Yang D., Liu N., Zuo C., et al. Innate host response in primary human hepatocytes with hepatitis C virus infection. PLoS One 2011, 6:e27552.
43. Zhang S., Kodys K., Li K., et al. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to Hepatitis C virus infection. Gastroenterology 2012, pii: S0016-5085(12)01550-8.
44. Zhang Y., Ma C.J., Wang J.M., et al. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS One 2011, 6:e19664.